BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27614264)

  • 21. VDR FokI polymorphism is associated with a reduced T-helper cell population under vitamin D stimulation in type 1 diabetes patients.
    Morán-Auth Y; Penna-Martinez M; Badenhoop K
    J Steroid Biochem Mol Biol; 2015 Apr; 148():184-6. PubMed ID: 25576905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormalities of the bone marrow immune microenvironment in patients with immune thrombocytopenia.
    Song Y; Wang YT; Huang XJ; Kong Y
    Ann Hematol; 2016 May; 95(6):959-65. PubMed ID: 26994009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system.
    Baeke F; Korf H; Overbergh L; van Etten E; Verstuyf A; Gysemans C; Mathieu C
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):221-7. PubMed ID: 20302932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1α,25-dihydroxyvitamin D3 in combination with transforming growth factor-β increases the frequency of Foxp3⁺ regulatory T cells through preferential expansion and usage of interleukin-2.
    Chambers ES; Suwannasaen D; Mann EH; Urry Z; Richards DF; Lertmemongkolchai G; Hawrylowicz CM
    Immunology; 2014 Sep; 143(1):52-60. PubMed ID: 24673126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effect of 1α,25-dihydroxyvitamin D3 on effector CD4+ T cell induced injury in human renal proximal tubular epithelial cells.
    Chung BH; Kim BM; Doh KC; Cho ML; Kim KW; Yang CW
    PLoS One; 2017; 12(2):e0172536. PubMed ID: 28245293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of peripheral blood T cell subsets in children with idiopathic thrombocytopenic purpura].
    Xiao H; Liu F; Wu CL; Yang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):722-5. PubMed ID: 16928308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A study of immunocyte subsets and serum cytokine profiles before and after immunal suppression treatment in patients with immune thrombocytopenia].
    Li W; Wang X; Li J; Liu M; Feng J
    Zhonghua Nei Ke Za Zhi; 2016 Feb; 55(2):111-5. PubMed ID: 26875579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
    Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
    J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
    Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
    Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs.
    Musiol IM; Feldman D
    Endocrinology; 1997 Jan; 138(1):12-8. PubMed ID: 8977379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polarization and apoptosis of T cell subsets in idiopathic thrombocytopenic purpura.
    Chang-Lin WU; Jian-Cheng XU; Fang LI; Hong XI; Xue-Min ZH; Qun CH; Xue-Wen LV
    Int J Lab Hematol; 2007 Jun; 29(3):177-84. PubMed ID: 17474894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effect of 25(OH)D3 and 1,25(OH)2D3 on Th17 cell differentiation.
    Fawaz L; Mrad MF; Kazan JM; Sayegh S; Akika R; Khoury SJ
    Clin Immunol; 2016 May; 166-167():59-71. PubMed ID: 27041081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Th17/Treg cells and Th cytokines in an improved immune thrombocytopenia mouse model.
    Zhang G; Zhang P; Liu H; Liu X; Xie S; Wang X; Wu Y; Chang J; Ma L
    Hematology; 2017 Sep; 22(8):493-500. PubMed ID: 28300523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D-binding protein controls T cell responses to vitamin D.
    Kongsbak M; von Essen MR; Levring TB; Schjerling P; Woetmann A; Ødum N; Bonefeld CM; Geisler C
    BMC Immunol; 2014 Sep; 15():35. PubMed ID: 25230725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1α,25-Dihydroxyvitamin D
    Ishizawa M; Akagi D; Yamamoto J; Makishima M
    J Steroid Biochem Mol Biol; 2017 Sep; 172():55-61. PubMed ID: 28578001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-17-producing CD4+ T lymphocytes are increased in patients with primary immune thrombocytopenia.
    Zhou L; Xu F; Chang C; Tao Y; Song L; Li X
    Blood Coagul Fibrinolysis; 2016 Apr; 27(3):301-7. PubMed ID: 26484642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 35 may contribute to the loss of immunological self-tolerance in patients with primary immune thrombocytopenia.
    Sun T; Zhang D; Yang Y; Zhang X; Lv C; Fu R; Lv M; Liu W; Chen Y; Liu W; Huang Y; Xue F; Liu X; Zhang L; Li H; Yang R
    Br J Haematol; 2015 Apr; 169(2):278-85. PubMed ID: 25640666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunological functions of the vitamin D endocrine system.
    Hayes CE; Nashold FE; Spach KM; Pedersen LB
    Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):277-300. PubMed ID: 12887108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.